No Picture
News

Published Study Demonstrates Feasibility of a Blood Test to Predict Disease Progression and Metastasis in Localized Prostate Cancer

SAN DIEGO, May 30, 2019 /PRNewswire/ — Epic Sciences, Inc. announced today the publication of a six-year study demonstrating the clinical applicability of circulating tumor cells (CTCs) to predict prostate cancer progression and metastasis. The stu… […]

No Picture
News

NuVasive SpineTRACK Registry Successfully Meets 2018 Medicare Reporting Requirements For Merit-based Incentive Payments System

SpineTRACK represents the only industry-sponsored spine registry that qualified providers to receive positive payment adjustments up to seven percent on all Medicare reimbursements in 2020

SAN DIEGO, May 30, 2019 /PRNewswire/ — NuVasive, Inc. (NASDA… […]

No Picture
News

Inhibrx Announces Option Agreement for Development and Commercialization of INBRX-101 (AAT-Fc) Outside of the United States and Canada with Chiesi Group

– Up to $162.5M in upfront, cost sharing and milestone payments, and escalating royalties into the high teens assuming exercise of the option

SAN DIEGO, May 30, 2019 /PRNewswire/ — Inhibrx, Inc. (“Inhibrx”), a clinical-stage biotechnology company de… […]

No Picture
News

Calidi Biotherapeutics Announces The Appointment Of Seasoned Biotech Executive Dr. Ashok Srivastava To Their Scientific Advisory Board

SAN DIEGO, May 30, 2019 /PRNewswire/ — Calidi Biotherapeutics, Inc., a clinical-stage biotechnology company at the forefront of oncolytic virus-based immunotherapies for cancer, today announced the appointment of seasoned biotech executive: Dr. As… […]